Table 1:
Final diagnoses and CYFRA 21-1 levels.
| Oncological disease | n | Non-oncological disease | n |
|---|---|---|---|
| Lung cancer | Hepatopathy | 31 | |
| Adenocarcinoma | 9 | Renal insufficiency | 26 |
| Squamous cell carcinoma | 6 | Chronic obstructive pulmonary disease (COPD) | 21 |
| Carcinoid tumor | 2 | Urinary infection | 10 |
| Mucoepidermoid carcinoma | 1 | Respiratory infection | 9 |
| Non-small cell carcinoma (unspecified) | 6 | Heart failure | 9 |
| Bladder cancer | Gastritis | 5 | |
| Adenocarcinoma | 3 | Emphysema | 4 |
| Metastasic cancer | |||
| Metastatic breast cancer | 1 | Other benign diseases | 137 |
| Metastatic colon cancer | 1 | (iron deficiency anemia, dyspnea, cholecystitis, without disease, diarrhea, anxiety, headache, polyps and constitutional syndrome) | |
| Metastatic gastric cancer | 1 | ||
| Metastatic melanoma | 1 | ||
| Metastatic tumor (unspecified origin) | 1 | ||
| Total, n | 32 | 252 | |
| CYFRA 21-1, median (IQR) | 4.75 (3.89–7.70) | CYFRA 21-1, median (IQR) | 1.20 (1.10–1.30) |
CYFRA 21-1 levels: median (ng/mL) and IQR (interquartile range).